Gastric Neuroendocrine Tumors, Diagnosis and Management
PDF
Cite
Share
Request
Review
P: 263-269
November 2021

Gastric Neuroendocrine Tumors, Diagnosis and Management

Nucl Med Semin 2021;7(3):263-269
1. Yeditepe Üniversitesi Tıp Fakültesi, Gastroenteroloji Anabilim Dalı, İstanbul, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Neuroendocrine tumors are derived from neuroendocrine cells which are commonly found in gastrointestinal system. Neuroendocrine cells take the electrical signals from the nervous system, convert them into hormonal signals with production of hormones, peptides and amines. As neuroendocrine cells are ubiquitous in our body, but NETs usually locates in the gastrointestinal (55%) or in the bronchopulmonary system (25%). The incidence and prevalence of NETs have been increasing over the years possibly due to increased awareness, and widespread use of endoscopy and imaging studies for various gastrointestinal diseases.

References

1Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
2Sato Y, Hashimoto S, Mizuno K, Takeuchi M, Terai S. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol 2016;22:6817-6828.
3Laird AM, Libutti SK. Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surg Oncol Clin N Am 2020;29:253-266.
4Dasari A, Shen C, Halperin D, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 2017;3:1335-1342.
5Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76:182-188.
6Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol 2020;12:791-807.
7Riechelmann RP, Weschenfelder RF, Costa FP, et al. Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group. Ecancermedicalscience 2017;11:716.
8Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G. Gastric Carcinoids. Endocrinol Metab Clin North Am 2018;47:645-660.
9Carvão J, Dinis-Ribeiro M, Pimentel-Nunes P, Libânio D. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE Port J Gastroenterol 2021;28:336-348.
10Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB. Management of Gastrointestinal Neuroendocrine Tumors. Clin Med Insights Endocrinol Diabetes 2019;12:1179551419884058.
11Han J, Chang KJ. Endoscopic Ultrasound-Guided Direct Intervention for Solid Pancreatic Tumors. Clin Endosc 2017;50:126-137.
12Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L. Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 2000;343:551-554.
13Pavel M, Öberg K, Falconi M, et al. Electronic address: [email protected]. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020;31:844-860.
14Gluckman CR, Metz DC. Gastric Neuroendocrine Tumors (Carcinoids). Curr Gastroenterol Rep 2019;21:13.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House